| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.2 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.23 | 0.2 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |